Safety is not established: a review found just 3 human studies covering 30 people, all with poor-quality evidence. The review examined human research on BPC-157, a lab-made substance based on a stomach protein. It is sold for tissue repair but lacks approval for human use. Researchers searched research databases and a trial registry through June 1, 2026. Only three studies met their review rules. Most evidence so far has come from animals. One study looked back at 16 people given injections into their knees. They had Joint Pain affecting the knee. Another looked back at 12 people with a long-term bladder pain condition. They received BPC-157 directly into the bladder. The third tested safety in just 2 people given it through a vein. The article reports symptom improvement in most people across the studies. None reported side effects linked to treatment. But no reported side effects does not establish safety, especially with so few people studied. All three studies lacked a group that did not receive BPC-157. That makes it impossible to separate its effects from natural healing or other treatment. The reviewers rated every study as poor quality. Their confidence in the overall evidence was very low. For BioSocial members tracking recovery, this is a reason to separate progress from proof. Dated pain scores and notes on daily tasks can describe personal changes. Recording other treatments and routine changes adds context when comparing notes here. Those records can support a useful discussion, but cannot establish safety or cause. What have your own recovery records shown, and what else changed during that time?